Stay updated on AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.

Latest updates to the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record history includes a new revision entry v3.5.4, indicating a subsequent update to the study’s listing in ClinicalTrials.gov.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a system-level update for this page. The visible study data and navigation remain unchanged.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision history now shows v3.4.3 and removes v3.4.2 in the page footer.SummaryDifference0.0%

- Check102 days agoChange DetectedA new site revision entry (v3.4.2) was added, and the old site-wide notice about government funding lapses as well as the prior revision entry (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.